83 FR 28231 - Advisory Committee on Breast Cancer in Young Women (ACBCYW)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 83, Issue 117 (June 18, 2018)

In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Advisory Committee on Breast Cancer in Young Women (ACBCYW). This meeting is open to the public, limited only by audio phone lines (100 audio lines available and 100 web conference lines available).

[Federal Register Volume 83, Number 117 (Monday, June 18, 2018)]
[Notices]
[Pages 28231-28232]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-13047]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Breast Cancer in Young Women (ACBCYW)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Advisory Committee on Breast 
Cancer in Young Women (ACBCYW). This meeting is open to the public, 
limited only by audio phone lines (100 audio lines available and 100 
web conference lines available).

DATES: The meeting will be held on August 6, 2018, 1:00 p.m. to 5:00 
p.m., EDT. Registration must be submitted no later than July 31, 2018 
(See SUPPLEMENTARY INFORMATION for how to register).

ADDRESSES: The public is also welcome to listen to the meeting by 
accessing the call-in number, 1-888-989-0726, passcode, 5698676 (100 
lines are available). The web conference access is https://adobeconnect.cdc.gov/r1hixcynbai/. Online registration is required (See 
SUPPLEMENTARY INFORMATION for how to register).

FOR FURTHER INFORMATION CONTACT: Temeika L. Fairley, Ph.D., Designated 
Federal Officer, National Center for Chronic Disease Prevention and 
Health Promotion, CDC, 5770 Buford Highway NE, Mailstop K52, Atlanta, 
Georgia, 30341, Telephone (770) 488-4518, Fax (770) 488-4760. Email: 
[email protected].

SUPPLEMENTARY INFORMATION: 
    How to register for the meeting: All ACBCYW Meeting participants 
must register online at least 7 business days in advance at https://www.cdc.gov/cancer/breast/what_cdc_is_doing/conference.htm. Please 
complete all the required fields before submitting your registration, 
and submit no later than July 31, 2018.
    Purpose: The committee provides advice and guidance to the 
Secretary, HHS; the Assistant Secretary for Health; and the Director, 
CDC, regarding the formative research, development, implementation and 
evaluation of evidence-based activities designed to prevent breast 
cancer (particularly among those at heightened risk) and promote the 
early detection and support of young women who develop the

[[Page 28232]]

disease. The advice provided by the Committee will assist in ensuring 
scientific quality, timeliness, utility, and dissemination of credible 
appropriate messages and resource materials.
    Matters to be Considered: The agenda will include discussions on 
current and emerging topics related to breast cancer in young women. 
These will include public health communication, breast cancer in young 
women digital and social media campaign, CDC updates, and updates from 
the field. Agenda items are subject to change as priorities dictate.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2018-13047 Filed 6-15-18; 8:45 am]
 BILLING CODE 4163-19-P